A Bold Idea for the NIH
Too many people don’t believe anymore in the American dream. But if you can’t dream big, you can’t accomplish big things. Today, I’d like to... Read More
Your Edge In Biotech.
Frontpoints Latest Articles
Our Communities, and Biotech, Need Local Journalism
National traumas force us out of our comfort zones. They can force us to search, to ask new questions, to think deeper about our world.... Read More
Biotech Is Radiant In a Dark Moment
The virus, at the start of a New Year, has arrived on all seven continents. Even Antarctica. An estimated 2 million people have died worldwide... Read More
A Triumph of the Scientific Enterprise – Industry, Academia, and Government
Vaccines for COVID-19 are here. Some are looking for a fly in the ointment. But there’s no mistaking these vaccines protect 95 percent of people... Read More
Pfizer, BioNTech Vaccine Gets FDA Advisory OK. Now Comes More Hard Work
The good news this week was really one of those good news / bad news stories. An expert panel of FDA vaccine advisors looked at... Read More
AZ’s Muddy Result, Regeneron Cocktail OK’d, and Biogen, Sage Bet Big on Depression
Take two weeks between Frontpoints columns, and a lot of stuff happens. On Monday Nov. 23, AstraZeneca presented a muddy picture from its Phase III... Read More
Moderna, Pfizer Nail COVID-19 Vaccines. Now Comes the Hard Part
It wasn’t the dominant headline it should have been, and few are in the mood to celebrate with the pandemic out of control, but this... Read More
Pfizer, BioNTech’s Watershed Moment, Lilly Antibody Gets EUA, & The Rebuilding Begins
First thing Monday, we all woke up to the brightest ray of light in this dark year. Pfizer and Germany-based BioNTech reported that their vaccine... Read More